Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 19-Mar-24 8:54 PM View:  | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 45,494 | $39.22 | $1,784,270.00 | (21%) 220.1K to 174.6K | |
| 21-Feb-24 7:03 PM View: | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Feb-24 | Grant | 99,000 | -- | -- | 82% 121.1K to 220.1K | |
| 05-Feb-24 6:53 PM View: | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Option Exercise | 14,125 | -- | -- | 13% 111.33K to 125.46K | |
| 05-Feb-24 6:53 PM View: | Rhythm Pharmaceuticals, Inc. (RYTM) | 01-Feb-24 | Planned Option Sale | 4,361 | $45.06 | $196,507.00 | (3%) 125.46K to 121.1K | |
| 31-Mar-21 4:08 PM View: | Rhythm Pharmaceuticals, Inc. (RYTM) | 30-Mar-21 | Market Purchase | 10,000 | $20.17 | $201,713.00 | 10% 101.33K to 111.33K | < 1% |
| 19-Nov-20 8:26 PM View: | Myokardia, Inc. (MYOK) | 17-Nov-20 | Disposition (change in control) | 4,100 | -- | -- | (100%) 4.1K to 0 | |
| 16-Jun-20 6:06 PM View: | Myokardia, Inc. (MYOK) | 13-Jun-20 | Option Exercise | 2,300 | -- | -- | 100% 0 to 2.3K | |
| 13-May-19 5:03 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Conversion | 300,536 | -- | -- | 45% 669.21K to 969.74K | |
| 13-May-19 5:03 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Conversion | 40,703 | -- | -- | 4% 969.75K to 1.01M | |
| 13-May-19 5:03 PM View: | Trevi Therapeutics, Inc. (TRVI) | 09-May-19 | Purchase | 11,250 | $10.00 | $112,500.00 | 1% 1.01M to 1.02M | |
| 10-Oct-17 4:24 PM View: | Rhythm Pharmaceuticals, Inc. (RYTM) | 10-Oct-17 | Conversion | 54,525 | -- | -- | 250% 21.81K to 76.33K | |
| 10-Oct-17 4:24 PM View: | Rhythm Pharmaceuticals, Inc. (RYTM) | 10-Oct-17 | Private Purchase | 25,000 | $17.00 | $425,000.00 | 33% 76.33K to 101.33K | |
| 17-Jan-13 11:22 AM View: | Savient Pharmaceuticals Inc. (SVNTQ) | 07-Jan-13 | Grant | 12,644 | $1.17 | $14,793.50 | 100% 0 to 12.64K | (52%) |
| 06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition | 29,250 | $74.00 | $2,164,500.00 | (71%) 41.13K to 11.88K | (3%) |
| 06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Option Exercise | 29,250 | -- | -- | 246% 11.88K to 41.13K | |
| 06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 10,551 | $74.00 | $780,774.00 | (89%) 11.88K to 1.33K | (3%) |
| 06-Apr-11 11:44 AM View: | Genzyme Corp. (GENZ) | 04-Apr-11 | Disposition (change in control) | 1,326 | $74.00 | $98,124.00 | (100%) 1.33K to 0 | (3%) |
| 22-Sep-10 4:12 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 20-Sep-10 | Disposition (change in control) | 38,358 | -- | -- | (100%) 38.36K to 0 | |
| 26-May-10 6:26 PM View: | Genzyme Corp. (GENZ) | 25-May-10 | Market Option Sale | 2,732 | $45.60 | $124,579.00 | (19%) 14.1K to 11.37K | (12%) |
| 26-May-10 6:26 PM View: | Genzyme Corp. (GENZ) | 24-May-10 | Option Exercise | 8,083 | -- | -- | 134% 6.02K to 14.1K | |
| 25-May-10 2:20 PM View: | Genzyme Corp. (GENZ) | 21-May-10 | Option Exercise | 16,488 | $26.50 | $436,932.00 | 274% 6.02K to 22.51K | |
| 25-May-10 2:20 PM View: | Genzyme Corp. (GENZ) | 21-May-10 | Market Option Sale | 16,488 | $49.06 | $808,901.00 | (73%) 22.51K to 6.02K | 1% |
| 05-Apr-10 4:01 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 01-Apr-10 | Grant | 2,746 | $3.46 | $9,501.16 | 8% 35.61K to 38.36K | (2%) |
| 05-Jan-10 4:07 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 04-Jan-10 | Grant | 9,612 | $0.99 | $9,499.56 | 100% 0 to 9.61K | |
| 24-Apr-09 10:08 AM View: | Genzyme Corp. (GENZ) | 23-Apr-09 | Market Purchase | 2,000 | $51.95 | $103,906.00 | 56% 3.55K to 5.55K | 1% |
| 12-Feb-09 11:44 AM View: | Genzyme Corp. (GENZ) | 30-Dec-08 | Gift | 120 | -- | -- | 4% 3.21K to 3.33K | |
| 12-Feb-09 11:44 AM View: | Genzyme Corp. (GENZ) | 30-Dec-08 | Gift | 120 | -- | -- | (4%) 3.33K to 3.21K | |
| 12-Feb-09 11:44 AM View: | Genzyme Corp. (GENZ) | 27-Aug-08 | Gift | 13 | -- | -- | (< 1%) 3.23K to 3.21K | |
| 18-Aug-08 1:58 PM View: | Genzyme Corp. (GENZ) | 15-Aug-08 | Option Exercise | 17,790 | $20.59 | $366,296.00 | 552% 3.23K to 21.02K | 283% |
| 18-Aug-08 1:58 PM View: | Genzyme Corp. (GENZ) | 15-Aug-08 | Market Option Sale | 17,790 | $83.19 | $1,479,950.00 | (85%) 21.02K to 3.23K | 37% |
| 04-Jan-08 3:26 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 02-Jan-08 | Grant | 6,000 | -- | -- | 30% 20.0K to 26.0K | |
| 05-Jan-07 4:42 PM View: | Penwest Pharmaceuticals Co. (PPCO.PK) | 03-Jan-07 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K |